-+ 0.00%
-+ 0.00%
-+ 0.00%

Beam Therapeutics announces annual shareholder meeting via webcast

PUBT·04/17/2026 20:06:38
Listen to the news
Beam Therapeutics announces annual shareholder meeting via webcast
  • Beam Therapeutics scheduled 2026 annual stockholder meeting for June 3, 2026 in virtual format.
  • Director elections set for Class III seats, covering John Evans, John Maraganore, Ph.D., Christi Shaw.
  • Shareholder vote to ratify Deloitte & Touche as independent registered public accounting firm for year ending Dec. 31, 2026.
  • Advisory vote slated on named executive officer compensation.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beam Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-161512), on April 17, 2026, and is solely responsible for the information contained therein.